About Anne Klibanski, MD

Anne Klibanski, MD is a clinician in the Neuroendocrine Clinical Center and Chief of the Neuroendocrine Unit at the Massachusetts General Hospital, and the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School.  She is a clinical researcher who studies pituitary tumors and the impact that pituitary and hypothalamic  disorders have on body composition, including low bone mass..  Awards in recognition of her work have included The Endocrine Society Clinical Investigator Award and the British Trust Medal.  She is the author of more than 350 peer-reviewed publications and has served on the Board of the NIH NIDDK Board of Counselors and on the Editorial Board of the Journal of Clinical Endocrinology and Metabolism. She is past-president of the Pituitary Society and serves on its Board. She has been involved in leadership positions of many educational programs sponsored by the Endocrine Society, the Pituitary Society and many patient advocacy groups to teach physicians and patients about pituitary tumors and neuroendocrine disorders.

Departments, Centers, & Programs:

Clinical Interests:



Mass General Endocrinology: Neuroendocrine & Pituitary Tumor Clinical Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-7948

Medical Education

  • MD, New York University
  • MD, New York University School of Medicine
  • Residency, Bellevue Hospital
  • Residency, Bellevue Hospital Center
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine
  • Internal Medicine, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Anne Klibanski is a clinical / translational investigator whose research has focused on two areas:

  • The pathogenesis and development of new therapies for patients with pituitary tumors and
  • An understanding of how neuroendocrine disorders can lead to low bone mass and the risk for osteoporosis. Specific research has focused on understanding acromegaly, prolactinomas, Cushing's disease and clinically non-functioning pituitary tumors.


Reviews: Comments and Ratings